Shingles Market
- The Shingles Market is expected to strengthen as awareness of the disease increases and more effective interventions are being developed.
- The leading Shingles Companies working in the market include Curevo Inc., Green Cross Corporation, Immorna Therapeutics Inc. ICON plc, Pascoe Pharma, Merck Sharp & Dohme LLC, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Jiangsu Rec-Biotechnology Co., Ltd., Changchun BCHT Biotechnology Co., Kaiser Permanente, Astellas Pharma Inc., Epiphany Biosciences, Yung Shin Pharm. Ind. Co., Ltd., and others.
Request for unlocking the CAGR of the Shingles Drugs Market
DelveInsight's "Shingles Drugs Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Shingles, historical and forecasted epidemiology as well as the Shingles market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
The Shingles Drugs Market Report provides current treatment practices, emerging drugs, Shingles market share of the individual therapies, current and forecasted Shingles market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Shingles treatment market practices/algorithms, Shingles market drivers and market barriers, and Shingles unmet needs to curate the best of the opportunities and assess the underlying potential of the Shingles market.
Study Period | 2019 to 2032 |
Forecast Period | 2023 to 2032 |
Geographies Covered |
|
Shingles Drugs Market |
|
Shingles Market Size | |
Shingles Companies |
|
Shingles Treatment Market
The DelveInsight’s Shingles treatment market report gives a thorough understanding of the Shingles by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment. The Shingles treatment market has witnessed significant growth and evolution as the healthcare industry continues to address the challenges associated with herpes zoster, commonly known as shingles. Shingles is a viral infection caused by the reactivation of the varicella-zoster virus, which also causes chickenpox. The market for shingles treatment is driven by the increasing incidence of the disease, primarily among the aging population and individuals with compromised immune systems.
Shingles Diagnosis
Shingles diagnosis typically relies on a combination of clinical evaluation and, in some cases, laboratory tests. The distinctive rash that characterizes shingles is often the primary visual cue for healthcare professionals. This segment of the report covers the detailed diagnostic methods or tests for Shingles.
Shingles Treatment
Shingles treatment aims to alleviate symptoms, promote healing, and prevent complications. Antiviral medications, such as acyclovir, valacyclovir, and famciclovir, are commonly prescribed to reduce the severity and duration of the rash. It covers the details of conventional and current medical therapies available in the Shingles market for the treatment of the condition. It also provides Shingles treatment algorithms and guidelines in the United States, Europe, and Japan.
Shingles Epidemiology
The Shingles epidemiology section provides insights about the historical and current Shingles patient pool and forecasted trends for individual seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Shingles market report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Key Findings
The disease epidemiology covered in the report provides historical as well as forecasted Shingles epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
Country Wise- Shingles Epidemiology
The Shingles epidemiology segment also provides the Shingles epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Unlock comprehensive insights! Click Here to Purchase the Full Epidemiology Report @ Shingles Prevalence
Shingles Drugs Market Chapters
The drug chapter segment of the Shingles Drugs Market report encloses a detailed analysis of Shingles marketed drugs and late-stage (Phase-III and Phase-II) Shingles pipeline drugs. It also helps to understand the Shingles clinical trials details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug, and the latest Shingles news and press releases.
Shingles Marketed Drugs
The Shingles Drugs Market report provides the details of the marketed products/off-label treatments available for Shingles treatment.
Shingles Emerging Drugs
The Shingles Drugs Market report provides the details of the emerging therapies under the late and mid-stage of development for Shingles treatment.
Shingles Market Outlook
The Shingles market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Shingles market trends by analyzing the impact of current Shingles therapies on the market, Shingles unmet needs, Shingles market drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the Shingles market trend of each marketed drug and late-stage Shingles pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing Shingles patient pool, covered patient segment, expected launch year, competition with other Shingles therapies, brand value, their impact on the Shingles market and view of the key Shingles companies. The calculated Shingles market outlook data are presented with relevant tables and graphs to give a clear view of the market at first sight.
"According to DelveInsight, the Shingles Therapeutics Market in 7MM is expected to witness a major change in the study period 2019-2032"
Key Findings
This section includes a glimpse of the Shingles therapeutics market in 7MM.
The United States Shingles Market Outlook
This section provides the total Shingles market size and Shingles market size by therapies in the United States.
EU-5 Countries: Shingles Market Outlook
The total Shingles market size and Shingles market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.
Japan Shingles Market Outlook
The total Shingles market size and Shingles market size by therapies in Japan is also mentioned.
Shingles Recent Developments
- In January 2025, GSK plc announced that the US Food and Drug Administration (FDA) has accepted for review its regulatory application for a prefilled syringe presentation of Shingrix (GSK's Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster).
Shingles Drugs Uptake
This section focuses on the rate of uptake of the potential Shingles drugs recently launched in the Shingles market or expected to be launched in the market during the study period 2019-2032. The analysis covers Shingles market uptake by drugs; patient uptake by therapies; and sales of each drug. Shingles Drugs Uptake helps in understanding the drugs with the most rapid uptake, and reasons behind the maximal use of new Shingles drugs, and allows the comparison of the drugs based on Shingles market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Shingles Pipeline Development Activities
The Shingles pipeline segment provides insights into different therapeutic candidates in Phase II and Phase III stages. It also analyses Shingles companies involved in developing targeted therapeutics.
Development Activities
The Shingles pipeline segment covers detailed information on collaborations, acquisitions, and mergers, licensing, patent details, and other information for Shingles emerging therapies.
Take Your Research to the Next Level! Click Here to Get Access to the Full Pipeline Report @ New Shingles Drugs
Reimbursement Scenario
Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a Shingles Drugs Market report, we consider reimbursement to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.
KOL- Views
To keep up with current Shingles market trends, we take KOLs and SMEs ' opinion working in the Shingles domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and Shingles emerging therapies treatment patterns or Shingles market trends. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the Shingles unmet needs.
Competitive Intelligence Analysis
We perform Competitive and Market Intelligence analysis of the Shingles Therapeutics Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies, etc. The inclusion of the analysis entirely depends upon the data availability.
Shingles Therapeutics Market Report Scope
- The Shingles therapeutics market report covers a descriptive overview, explaining its causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
- Comprehensive insight has been provided into the Shingles epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and Shingles emerging therapies is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of the Shingles therapeutics market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The patient-based shingles market forecasting report provides an edge while developing business strategies, by understanding trends shaping and driving the global Shingles therapeutics market
Shingles Drugs Market Report Highlights
- In the coming years, the Shingles therapeutics market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the shingles therapeutics market
- The Shingles companies and academics are working to assess challenges and seek opportunities that could influence Shingles R&D. The Shingles therapies under development are focused on novel approaches to treat/improve the disease condition
- Shingles companies are involved in developing Shingles therapies. The launch of emerging therapies will significantly impact the Shingles therapeutics market
- A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Shingles
- Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed Shingles clinical trials profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities
Shingles Therapeutics Market Report Insights
- Patient-Based Shingles Market Forecasting
- Therapeutic Approaches
- Shingles Pipeline Analysis
- Shingles Market Size
- Shingles Market Trends
- Shingles Therapeutics Market Opportunities
- Impact of Upcoming Shingles Therapies
Shingles Therapeutics Market Report Key Strengths
- 10 Years- Shingles Market Forecast
- 7MM Coverage
- Shingles Epidemiology Segmentation
- Key Cross Competition
- Highly Analyzed Shingles Therapeutics Market
- Shingles Drugs Uptake
Shingles Treatment Market Report Assessment
- Current Shingles Treatment Market Practices
- Shingles Unmet Needs
- Shingles Pipeline Drugs Profiles
- Shingles Therapeutics Market Attractiveness
- Shingles Market Drivers
- Shingles Market Barriers
Key Questions
Shingles Treatment Market Insights:
- What was the Shingles drugs market share (%) distribution in 2019 and what it would look like in 2032?
- What would be the Shingles market size as well as market size by therapies across the 7MM during the forecast period (2023-2032)?
- What are the key findings about the Shingles market across 7MM and which country will have the largest Shingles market size during the forecast period (2023-2032)?
- At what CAGR, the Shingles therapeutics market is expected to grow by 7MM during the forecast period (2023-2032)?
- What would be the Shingles market outlook across the 7MM during the forecast period (2023-2032)?
- What would be the Shingles market growth till 2032, and what will be the resultant market Size in the year 2032?
- How would the Shingle's unmet needs affect the market dynamics and subsequent analysis of the associated trends?
Shingles Epidemiology Insights:
- What are the disease risk, burden, and regional/ethnic differences of the Shingles?
- What are the key factors driving the epidemiology trend for seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
- What is the historical Shingles patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
- What would be the forecasted Shingles patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
- Where will be the growth opportunities in the 7MM for the patient population of Shingles?
- Out of all 7MM countries, which country would have the highest prevalent population of Shingles during the forecast period (2023-2032)?
- At what CAGR the Shingles patient population is expected to grow by 7MM during the forecast period (2023-2032)?
Current Shingles Treatment Market Scenario, Marketed Drugs and Emerging Therapies:
- What are the current options for the Shingles treatment in addition to the approved therapies?
- What are the current treatment guidelines for Shingles treatment in the USA, Europe, and Japan?
- What are the Shingles marketed drugs and their respective MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
- How many companies are developing therapies for the Shingles treatment?
- How many therapies are in development by each company for Shingles treatment?
- How many are Shingles emerging therapies in mid-stage, and late stages of development for Shingles treatment?
- What are the key collaborations (Industry - Industry, Industry-Academia), Mergers and acquisitions, and licensing activities related to the Shingles therapies?
- What are the recent novel therapies, targets, mechanisms of action, and technologies being developed to overcome the limitations of existing therapies?
- What are the Shingles clinical trials going on and their status?
- What are the current challenges faced in Shingle's drug development?
- What are the key designations that have been granted for the emerging therapies for Shingles?
- What are the global historical and forecasted Shingles market?
Reasons to buy
- The patient-based shingles market forecasting report will help in developing business strategies by understanding trends shaping and driving the Shingles market
- To understand the future market competition in the Shingles market and Insightful review of the key Shingles market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Shingles in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming Shingles companies in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for the Shingles market
- To understand the future market competition in the Shingles market
Related Article- Commencement of AAIC; GSK’s Shingles Vaccine Expanded Approval; Pfizer/ BioNtech Agreement with Biovac; Another Failure in Ulcerative Colitis Trial
For More In-depth Information @ Latest DelveInsight Blogs